The Aastrom experience

Table 2 Contribution to treatment failure composite endpoint in treated patients (Ixmyelocel-T or control)

Endpoint: n (%)	Ixmyelocel-T N = 48	Control N = 24
Major amputation	6	4
All-cause mortality	2	1
Doubling in total wound surface area^a	5	7
De novo gangrene	6	4
Total	19 (39.6%)^b	16 (66.7%)^b

^aPatient must have come into the study with a wound to be eligible to contribute to this event. ^bP = 0.0451, Fisher's exact test.

ISSN: 1757-6512